KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Long-Term Deferred Tax: 2010-2019

Historic Long-Term Deferred Tax for Emergent BioSolutions (EBS) over the last 9 years, with Dec 2019 value amounting to $13.4 million.

  • Emergent BioSolutions' Long-Term Deferred Tax was N/A to $17.6 million in Q1 2020 from the same period last year, while for Mar 2020 it was $17.6 million, marking a year-over-year change of. This contributed to the annual value of $13.4 million for FY2019, which is negligibly% changed negligibly from last year.
  • Latest data reveals that Emergent BioSolutions reported Long-Term Deferred Tax of $13.4 million as of FY2019, which was down 0.00% from $13.4 million recorded in FY2018.
  • Emergent BioSolutions' 5-year Long-Term Deferred Tax high stood at $13.4 million for FY2018, and its period low was $2.8 million during FY2017.
  • In the last 3 years, Emergent BioSolutions' Long-Term Deferred Tax had a median value of $13.4 million in 2019 and averaged $9.9 million.
  • In the last 5 years, Emergent BioSolutions' Long-Term Deferred Tax tumbled by 54.07% in 2017 and then skyrocketed by 378.57% in 2018.
  • Emergent BioSolutions' Long-Term Deferred Tax (Yearly) stood at $11.3 million in 2015, then tumbled by 45.99% to $6.1 million in 2016, then plummeted by 54.07% to $2.8 million in 2017, then skyrocketed by 378.57% to $13.4 million in 2018, then remained steady at $13.4 million in 2019.